Since epidemiological studies first demonstrated a potential positive effect of metformin in reducing cancer incidence and mortality, there has been an increased interest in not only better understanding metformin's mechanisms of action but also in exploring its potential anti-cancer effects. In this review, we aim to summarise the current evidence exploring a role for metformin in prostate cancer therapy.Preclinical studies have demonstrated a number of antineoplastic biological effects via ...Expand abstract
- Publication status:
- Peer review status:
- Peer reviewed
- Publisher's version
- Springer US Publisher's website
- Current Urology Reports Journal website
- Article: 46
- Publication date:
- Pubs id:
- Local pid:
- Copyright holder:
- Whitburn et al.
- Copyright date:
Copyright © 2017 The Authors.
This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.
Metformin and prostate cancer: a new role for an old drug
If you are the owner of this record, you can report an update to it here: Report update to this record